When was Mabtech founded?

Mabtech was founded in 1986 and raised its 1st funding round 30 years after it was founded.

Where is Mabtech located?

Mabtech is headquartered in Nacka, Sweden.

How many employees does Mabtech have?

As of Sep 30, 2026, the latest employee count at Mabtech is 127.

Is Mabtech a funded company?

Mabtech is a funded company, having raised an undisclosed amount across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 01, 2016.

When was the latest funding round of Mabtech?

Mabtech's latest funding was a $***** Grant (prize money) round on Oct 01, 2020, with participation from 1 investor.

Where does Mabtech rank among its competitors?

Mabtech ranks 5th amongst 277 active competitors, of which 16 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Pixelgen Technolgies, which secured $15.5M in Aug, 2026.

Who are the top competitors of Mabtech?

Mabtech's top competitors include Sino Biological, GenScript and Pixelgen Technolgies. Among them, Pixelgen Technolgies secured the most recent funding round in August, 2026.

Mabtech - 2026 Company Profile, Team, Funding & Competitors

Company Details

Mabtech develops antibodies and antibody-related kits and reagents. The product line of the company includes Antibodies, ELISA Kits, ELISpot Kits, and FluoroSpot Kits for various applications. It collaborates with research institutes to run R&D programs.

Website: www.mabtech.com/
Social
Email ID: *****@mabtech.com
Phone Number: +46 **********

Key Metrics

Founded Year

1986

Location

Nacka, Sweden

Stage

Acquired

Latest Funding Round

Grant (prize money), Oct 01, 2020, $*****

Investors

Merieux Equity Partners & 2 more

Ranked

5^th among 277 active competitors

Employee Count

127 as on Sep 30, 2026

Similar Companies

Sino Biological & 332 more

Exit Details

Acquired by EQT (Jan 09, 2024)

View Mabtech's full profile

Mabtech got acquired by EQT on Jan 09, 2024.

Click here to take a look at Mabtech's acquisition in detail

Mabtech has raised funding over 5 rounds. Its first funding round was on Sep 01, 2016. Its latest funding round was a Grant (prize money) round on Oct 01, 2020 for $*****. 1 investor participated in its latest round. Mabtech has 3 institutional investors.

Here is the list of recent funding rounds of Mabtech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 01, 2020	7317413	Grant (prize money)	6800743	2688796	5758006	3603043
Nov 26, 2019	6593248	PE	1602091	4754682	9990129	IK Partners
Apr 01, 2018	6223437	Grant (prize money)	6069775	7228584	5888207	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Mabtech's funding rounds and investors

Mabtech's employee count trend

Mabtech has 127 employees as of Sep 26. Here is Mabtech's employee count trend over the years:

Uncover Mabtech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Mabtech include Sino Biological, GenScript and Pixelgen Technolgies. Here is the list of Top 10 competitors of Mabtech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
2nd	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
3rd	Pixelgen Technolgies 2020, Stockholm (Sweden), Series B	Developer of ground-breaking technologies for biomedical research and diagnostics	$21.5M	Flat Capital, Industrifonden & 2 others	55/100
4th	Shanghai OPM Biosciences 2013, Pudong (China), Series B	Antibody culture media and vaccine culture products developer	$14.4M	CPE, China Life Great Health Fund & 5 others	54/100
5th	Mabtech 1986, Nacka (Sweden), Acquired	Develops antibodies and ELISA kits	-	IK Partners, Merieux Equity Partners & 1 others	53/100
6th	ITBMed 2016, Stockholm (Sweden), Series A	Developer of monoclonal antibodies to prevent transplant rejections	$87M	3E Bioventures Capital, Yonjin Capital & 2 others	51/100
7th	GeneTex 1997, Hsinchu (Taiwan), Early Stage	GeneTex is a manufacturer and supplier of bioreagents for life science research.	$4.3M	-	49/100
8th	Immuno-Biological Laboratories 1982, Fujioka (Japan), Public	Manufacture antibodies	-	Japan Asia Investment, Hokkaido Venture Capital ... & 3 others	49/100
9th	Allele Biotech 1999, San Diego (United States), Series B	cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs	$18M	NIH, HHS & 1 others	48/100
10th	Epitomics 2001, Burlingame (United States), Acquired	Life science reagents: antibodies, proteins, kits, and expert scientific support	$16.2M	Kenson Ventures, Sycamore Ventures & 1 others	48/100